DOJ Closes Criminal Probe Into Abbott's Baby Formula Plant

The U.S. Department of Justice (DOJ) has closed its criminal investigation into Abbott Laboratories' (NYSE:ABT) baby formula plant in Michigan, according to reports from Simply Wall St. The probe stemmed from alleged manufacturing lapses that contributed to a nationwide baby formula shortage. Authorities are now shifting focus to civil penalties rather than criminal charges.

Details of the Action

The DOJ investigated Abbott's Sturgis, Michigan plant, which was at the center of the 2022 U.S. baby formula shortage. The criminal case has been closed, but the DOJ continues to pursue civil penalties related to alleged manufacturing violations. The amount of potential civil fines has not been disclosed.

Company's Position

Abbott Laboratories has not yet issued an official statement following the closure of the criminal probe. However, the company has previously defended its practices, stating that it has taken corrective actions to improve quality and safety at the plant. A formal comment is expected soon.

Precedents and Context

This development follows the closure of the FDA's investigation into the same plant earlier this year, which also resulted in civil fines. The case is part of a broader regulatory crackdown on baby formula manufacturers in the U.S. after the shortage raised public health concerns.

Potential Financial Impact

Civil penalties are expected to result in financial fines, but they are likely to be significantly lower than the potential costs of a criminal prosecution, which could have included harsher sanctions. The closure of the criminal probe removes a key legal uncertainty that had weighed on the stock, potentially boosting investor confidence.